Tablon, Elena D.

HRN: 28-68-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/21/2026
03/27/2026
IV
2.25 G
Q6h
CAP-HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: